F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the Company's goal is to offer patients greater and m

F-star Therapeutics Inc

Sold all FSTX

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Mike Pelech

Bought 49% more FSTX

New position in FSTX

Abilash Satya

Bought to close all FSTX

Sachin Katti

Bought to close 4% FSTX